Displaying 1-10 of 45.

Targeted therapies for non-small cell lung cancer

... It is a monoclonal antibody (a man-made version of a specific immune system
protein) that targets vascular endothelial growth factor (VEGF), a ...

http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-treating-targeted-therapies

Your Support Makes a Difference: Prostate Cancer

... cancer, we know that these cancers produce a product called vascular
endothelial growth factor (more commonly known as VEGF), which cancer ...

http://www.cancer.org/aboutus/drlensblog/post/2005/11/02/your-support-makes-a-difference-prostate-cancer.aspx

SOCIAL RELATIONSHIPS AND TUMOR ANGIOGENESIS ...

... Promoters of Angiogenesis: Vascular Endothelial Growth Factor (VEGF) and
Interleukin-6 (IL-6) ▪Key factors contributing to angiogenesis and ...

http://www.cancer.org/acs/groups/content/@behavioralresearchcenter/documents/document/acspc-036209.pdf

Cetuximab In Lung Cancer: A Small Step Forward

... NSCLC. However, bevacizumab focuses on a different target, called
vascular endothelial growth factor or VEGF. This target ...

http://www.cancer.org/aboutus/drlensblog/post/2008/06/01/cetuximab-in-lung-cancer-a-small-step-forward.aspx

Avastin Approved for Kidney Cancer

... of new blood vessels. It blocks vascular endothelial growth factor
(VEGF), a protein that stimulates blood vessel growth. ...

http://www.cancer.org/cancer/news/news/avastin-approved-for-kidney-cancer

Targeted therapy for cervical cancer

... It is a monoclonal antibody (a man-made version of a specific immune system
protein) that targets vascular endothelial growth factor (VEGF), a ...

http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-treating-targeted-therapy

Ramucirumab

... This drug attaches to a protein called vascular endothelial growth factor receptor
2 (VEGFR2), which is on the surface of some cells and is needed ...

http://www.cancer.org/acs/groups/cid/documents/webcontent/acspc-042589-pdf.pdf

Ramucirumab

... This drug attaches to a protein called vascular endothelial growth factor receptor
2 (VEGFR2), which is on the surface of some cells and is needed ...

http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/dietandnutrition/ramucirumab

Bevacizumab

... Bevacizumab attaches to a protein called vascular endothelial growth factor
(VEGF), which is required by the body to grow blood vessels. ...

http://www.cancer.org/treatment/treatmentsandsideeffects/guidetocancerdrugs/bevacizumab

Types of targeted therapy used today | American Cancer ...

... a multi-targeted kinase inhibitor because it's a type of vascular endothelial
(vas-ku-lur en-doe-THEE-lee-uhl) growth factor (VEGF) receptor inhibitor ...

http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/targetedtherapy/targeted-therapy-types